Intermediate biomarkers are biological alterations in tissue which sig
nal a stage of carcinogenesis between initiation and the development o
f a malignant tumor. Proliferation biomarkers are those that most sati
sfy the requisites for premorphological intermediate markers in the co
lorectal tumor progression. Cell proliferation changes in histological
ly normal intestinal mucosa are early events directly and closely asso
ciated with the morphogenesis of colorectal neoplasia. The transition
from the morphological stage and the latter's further progression can
be reliably monitored through the use of differentiation and genomic m
arkers. In particular the incidence and the degree of DNA aneuploidy a
re indicators of the risk of malignant transformation in colorectal ad
enomas. New ''regression-related'' biomarkers should be investigated f
or the planning of measures designed to bring about the regression of
premalignant lesions.